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Abstract 
The prevalence of posttraumatic stress disorder (PTSD) as it relates to people’s experiences 
of the COVID-19 pandemic has yet to determined. This study was conducted to determine 
rates of COVID-19 related PTSD in the Irish general population, the level of comorbidity 
with depression and anxiety, and sociodemographic risk factors associated with COVID-19 
related PTSD. A nationally representative sample of adults from the general population of the 
Republic of Ireland (N = 1,041) completed self-report measures of all study variables. The 
rate of COVID-19 related PTSD was 17.7% (95% CI = 15.35 - 19.99%: n=184), and 
comorbidity with generalized anxiety (49.5%) and depression (53.8%) was high. Meeting the 
diagnostic requirement for COVID-19 related PTSD was associated with younger age, male 
sex, living in a city, living with children, moderate and high perceived risk of COVID-19 
infection, and screening positive for anxiety or depression. Traumatic stress problems related 
to the COVID-19 pandemic are common in the general population. Our results show that 
health professionals responsible for responding to the COVID-19 pandemic should expect to 
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 Traumatic stress disorders are relatively common in the general population (Brewin et 
al., 2017), and a recent study found that in 2019 approximately 13% of the general adult 
population of the Republic of Ireland were suffering from a traumatic stress disorder (Hyland 
et al., 2020). In the 11th version of the International Classification of Diseases (ICD-11) 
(WHO, 2018), Posttraumatic Stress Disorder (PTSD) is described in terms of six core 
symptoms distributed across three clusters including re-experiencing in the here and now, 
avoidance of reminders, and hyperarousal. PTSD is a chronic disorder with research 
suggesting that approximately 40% of affected persons continue to exhibit significant 
symptoms ten years after its onset (Kessler et al., 1995). Those with PTSD are between two 
and six times more likely to present with psychiatric comorbidities including depression, 
anxiety, and suicidality (Bresleau et al., 1991; Karatzias et al., 2019). PTSD has also been 
shown to be associated with significant economic costs due to work impairment, 
hospitalization, and health visits (Ferry et al., 2015). Thus, early intervention and appropriate 
management of PTSD is important. 
 Data derived from previous outbreaks of respiratory infections such as the Severe 
Acute Respiratory Syndrome (SARS) demonstrate that being infected, or the threat of being 
infected, can be a potentially traumatic event and increase risk of PTSD (Mak et al., 2009; 
Cheng et al., 2006; Wu et al., 2009). The COVID-19 pandemic represents a threatening and 
potentially traumatic event as it can lead to hospitalisation and even death. Many 
governments, including in the Republic of Ireland, imposed extensive restrictions on freedom 
of movement, the closure of non-essential businesses, and the requirement to stay at home 
and restrict social contact to slow the spread of the contagion. We are unaware of any studies 
that have published findings on rates of PTSD in the general population in the context of the 
COVID-19 pandemic. Our own research group conducted parallel surveys of the general 
adult populations of the United Kingdom (UK) and the Republic of Ireland, and we have 
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reported elsewhere that 16.79% (95% CI = 15.16-18.42%) of adults in the UK screened 
positive for PTSD specifically related to their experiences with COVID-19 (Shevlin et al., 
under review). We also found that younger age, male sex, urban dwelling, having a higher 
number of children living in the home, lower income, and moderate and high perceived risk 
of becoming infected with COVID-19 were significantly associated with screening positive 
for COVID-19 related PTSD.  
 The current study was conducted to investigate three objectives. First, we sought to 
determine what proportion of the general adult population of Ireland screened positive for 
PTSD specifically related to their experiences of COVID-19 pandemic. Second, we sought to 
determine the levels of comorbidity for COVID-19 related PTSD with major depression and 
generalized anxiety. Third, we sought to identify the key sociodemographic risk factors 
associated with screening positive for COVID-19 related PTSD, with and without controlling 
for anxiety and depression.  
Method 
Participants and procedure 
Participants (N = 1,041) were recruited by the survey company Qualtrics using 
stratified quota sampling to ensure that the sample characteristics of sex, age, and region of 
Ireland matched known population parameters from the 2016 Irish census. Data collection 
started on 31st March 2020, 31 days after the first confirmed case of COVID-19 in the 
Republic of Ireland, 19 days after the first physical distancing measures were enacted (i.e., 
closure of all childcare and educational facilities), and two days after the Taoiseach (the 
Republic of Ireland’s Prime Minister) announced that people were not to leave their homes. 
The survey was completed on the 5th of April 2020. Participants had to be aged 18 years or 
older at the time of the survey and be able to complete the survey in English. Participants 
were contacted by the survey company via email and requested to participate. If consenting, 
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participants completed the survey online (median time of completion = 37.52 minutes) and 
were reimbursed by the survey company for their time. Ethical approval for the study was 
granted by the ethical review board of the REMOVED FOR REVIEW. The sample 
characteristics are presented in Table 1.  
Measures 
Traumatic stress: The International Trauma Questionnaire (Cloitre et al., 2018) is a 
self-report measure of ICD-11 PTSD. Participants were asked to answer the six PTSD 
symptom items “…in relation to your experience of the COVID-19 pandemic” and to 
“…indicate how much you have been bothered by that problem in the past month”. The 
PTSD symptoms are accompanied by three items measuring functional impairment caused by 
these symptoms. All items are answered on a five-point Likert scale ranging from 0 (Not at 
all) to 4 (Extremely), and a response of ≥ 2 (Moderately) is considered ‘endorsement’ of a 
symptom. A probable PTSD diagnosis requires at least one symptom to be endorsed from 
each symptom cluster and endorsement of at least one indicator of functional impairment. 
The psychometric properties of the ITQ scores have been demonstrated in multiple general 
population (Ben-Ezra et al., 2017; Cloitre et al., 2019) and clinical and high-risk samples 
(Hyland et al., 2017; Karatzias et al., 2016). The reliability of the PTSD items in this sample 
was high (α = .93). 
Depression: The Patient Health Questionnaire-9 (PHQ-9) (Kroenke et al., 2001) was 
used to screen participants for major depression. Respondents indicate how often they have 
been bothered by each symptom over the last two weeks using a four-point Likert scale 
ranging from 0 (Not at all) to 3 (Nearly every day). To identify participants likely to meet the 
criteria for probable major depression, a cut-off score of > 10 was used (Kroenke et al., 
2001). This cut-off produces good sensitivity (.85) and specificity (.89). The psychometric 
PTSD COVID-19   6 
 
properties of the PHQ-9 scores have been widely supported (Manea et al., 2012) and the 
reliability in the current sample was excellent (α = .91).  
Generalized anxiety: Symptoms of generalized anxiety disorder were measured using 
the Generalized Anxiety Disorder 7-item Scale (GAD-7) (Spitzer et al., 2006). Participants 
indicate how often they have been bothered by each symptom over the last two weeks on a 
four-point Likert scale (0 = Not at all, to 3 = Nearly every day). A cut-off score of > 10 was 
used, and this has been shown to have good sensitivity (.89) and specificity (.82) (Spitzer et 
al., 2006). The GAD-7 has been shown to produce reliable and valid scores in community 
studies (Hinz et al., 2017), and the reliability in the current sample was excellent (α = .94).  
Data analysis 
The proportion of the sample who met the diagnostic requirements for COVID-19 
related probable PTSD was first calculated. Rates of comorbidity for PTSD with depression 
and generalized anxiety were assessed using a chi-square test. Two binary logistic regression 
models were used to identify the risk factors associated with screening positive for COVID-
19 related PTSD. In the first model the predictor variables were age, sex (0 = males, 1 = 
females), urban dwelling (1 = City, 0 = Town, Suburb, or Rural), lost income due to COVID-
19 (“My household has lost income because of the coronavirus COVID-19 pandemic”: 1 = 
Yes, 0 = No), having children living at home (1 = Yes, 0 = No), being the lone adult in the 
household (1 = no other adult living in household, 0 = other adult(s) living in household), 
having a pre-existing health problem (“Were you diagnosed with a health condition (e.g. 
heart or lung disease; diabetes; cancer) before December 31st 2019 (i.e. before the start of the 
coronavirus COVID-19 outbreak)?”: 1 = Yes, 0 = No), and perceived risk of infection 
(“What do you think is your personal percentage risk of being infected with the COVID-19 
virus over the next month?” on a 0-100 scale: recoded as ‘Low’ (0 - 33), ‘Moderate’ (34 - 
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67), and ‘High’ (68 - 100)). In the second model, a variable representing those participants 
who met the criteria for either anxiety or depression was added as a predictor. 
Results 
The mean COVID-19 related PTSD symptom score was 5.07 (Mdn = 3.00, SD = 5.64, 
range = 0-24). In total, 17.7% (95% CI = 15.35 - 19.99%) of the sample met the diagnostic 
requirements for COVID-19 related PTSD. Of those who screened positive for PTSD, 53.8% 
met the criteria for depression (χ2 (1) = 122.45, p < .001), 49.5% met the criteria for 
generalized anxiety (χ2 (1) = 121.45, p < .001), and 60.3% met the criteria for either anxiety 
or depression (χ2 (1) = 119.13, p < .001).  
The binary logistic regression model of COVID-19 related PTSD was statistically 
significant (χ2 (13) = 178.73, p < .001), as was the model when the anxiety/depression 
variable was added as a predictor (χ2 (14) = 229.94, p < .001). The unadjusted and adjusted 
odds ratios are presented in Table 2. Without controlling for anxiety/depression, the three 
oldest age categories were less likely to screen positive for COVID-19 related PTSD 
compared to those in the 18-24 age category. Additionally, living in a city (AOR = 1.78), 
having children living at home (AOR = 1.46), having a pre-existing health condition (AOR = 
1.67), and perceiving your risk of COVID-19 infection in the next month as moderate (AOR 
= 2.65) and high (AOR = 5.66) were also associated with screening positive for COVID-19 
related PTSD. When the anxiety/depression variable was added to the model the estimates 
remained similar; the coefficient for the 45-54 year age band became non-significant, the 
coefficient for sex became significant indicting a lower risk for females, and the adjusted 
odds ratio for the anxiety/depression variable was high (AOR = 4.03). 
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Discussion 
 In this study we set out to determine the level of COVID-19 related traumatic distress 
in the general population of the Republic of Ireland, and to identify key risk factors 
associated with experiencing traumatic distress related to the pandemic. We found that just 
under one-in-five people (17.67%) met diagnostic requirements for PTSD. This figure is 
somewhat higher than the rate of traumatic stress disorders that was reported in the general 
adult population of Ireland in 2019 (i.e., 13.2%) (Hyland et al., 2020), but it is extremely 
similar to findings from our parallel survey conducted in the UK (16.79%) (Shevlin et al., 
under review). The current survey and the parallel survey in the UK were carried out within 
the first week of the lockdown measures being enacted. Thus, it appears that a significant 
proportion of the general adult populations of Ireland and the UK are being affected by 
COVID-19 related traumatic stress, and that rates of traumatic distress may have increased 
slightly during the initial lockdown period. Given the well-established capacity for humans to 
adapt to major stressful life events, this minor increase in rates of traumatic stress disorders is 
likely to be transitory, although further research is required to delineate the long term effects 
of COVID-19 pandemic. Following these participants across the pandemic – which our 
research group will do – will reveal if rates of traumatic stress decline as time proceeds. 
Nonetheless, even what current and past results (Hyland et al., 2020) show is that a 
significant proportion of the adult general population of the Republic of Ireland suffer from 
trauma-based psychopathology.  
Consistent with the wider trauma and PTSD literature (Karatzias et al., 2019), high 
levels of comorbidity with depression and generalized anxiety were evidenced for those who 
screened positive for COVID-19 related PTSD. Approximately half of all of those people 
who met diagnostic requirements for COVID-19 related PTSD also screened positive for 
depression, and also for generalized anxiety. These results indicate that those experiencing 
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traumatic stress about the COVID-19 pandemic are likely to be suffering from an array of 
mental health problems such as anxiety and depression. The results from the binary logistic 
regression also indicate that co-occurring anxiety or depression may be an additional risk 
factor for PTSD. 
The results of the binary logistic regression analysis indicated that screening positive 
for COVID-19 related PTSD was associated with younger age, urban dwelling, having 
children at home, having an existing health condition that increases risk of mortality from 
COVID-19, and having moderate and high perceived risk of COVID-19 infection within the 
next month. These findings were extremely consistent with our findings in the UK, and with 
the exception of having a pre-existing health condition, each of these variables were 
associated with COVID-19 related PTSD in the UK (Shevlin et al., under review). Notably, 
the dose-response effect observed in the current study for moderate and high levels of 
perceived risk of COVID-19 infection was also evidenced in the UK sample, and in these 
analyses remained significant after controlling for anxiety and depression. These findings are 
also consistent with findings during the SARS epidemic (Mak et al., 2009; Cheng et al., 
2006; Wu et al., 2009). These findings may be used by public health officials to identify 
people more effectively in different parts of society at risk of developing traumatic stress 
problems in response to the current pandemic.  
Several limitations should be noted. Firstly, all mental health problems were assessed 
using self-report measures, therefore, the extent to which people’s PTSD symptoms were 
directly tied to the COVID-19 pandemic could not be ascertained. Secondly, we only 
assessed PTSD symptoms in relation to the current pandemic and we did not also assess 
history of exposure to other traumatic events or previous PTSD diagnosis. Third, the current 
sample was drawn for the general adult population and was not inclusive of members of the 
population who were institutionalised at the time of the survey. Populations in hospitals, 
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prisons, and refugee centres, for example, are all known to have higher rates of PTSD and 
this poses a threat to the generalizability of these findings.  
Despite these limitations, the current study provides important and novel information 
about the rates of traumatic stress problems in the population related to the COVID-19 
pandemic. Taking these findings in conjunction with our highly congruent results from the 
UK general population, we can confidently conclude that approximately 17% of adults in the 
general population are reporting clinically relevant signs of PTSD. Furthermore, having 
traumatic stress problems is associated with younger age, living with children, living in a 
city, having an existing chronic health problem, and higher levels of perceived vulnerability 
to COVID-19. Clinicians and public health officials who will be responsible for the mental 
health response to COVID-19 should be aware that many people that they will encounter, and 
many people in society, will be suffering from PTSD. 
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Irish  74.8 
Irish Traveller 0.3 
Other White background 17.3 
African 1.9 
Other Black background 0.3 
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Chinese 0.4 
Other Asian 3.2 
Mixed Background 1.8 





Highest Education  
No qualification 1.2 
Finished mandatory schooling 6.4 
Finished secondary school 22.4 
Undergraduate degree 22.5 
Postgraduate degree 19.8 
Other technical qualification 27.9 






Employment status  
Full-time (self)/employed 43.3 
Part-time (self)/employed 15.7 
Retired 15.0 




Unemployed (disability or illness) 5.6 








Other religion 3.8 
Atheist 15.3 
Agnostic 7.5 
Lone adult in household  
Yes 18.4 
Children in the household  
Yes 39.7 
 
PTSD COVID-19   17 
 
Table 2. Binary Logistic Regression Results Predicting COVID-19 related PTSD Status (N = 1,041). 
  PTSD Unadjusted OR Adjusted ORa Adjusted ORb 
 N N (%)    
Age      
18-24 116 31 (26.7%) - - - 
25-34 200 64 (32.0%) 1.290 (.777 - 2.143) 1.013 (.581 - 1.767) 1.268 (.710 - 2.264) 
35-44 214 48 (22.4%) .793 (.471 - 1.336) .641 (.363 - .132) .942 (.517 -1.715) 
45-54 165 25 (15.2%) .490 (.271 - .885)* .414 (.217 - .789)** .668 (.342 -1.305) 
55-64 219 14 (6.4%) .187 (.095 - .370)*** .182 (.087 - .381)*** .323 (.150 -.695)** 
65+ 127 2 (1.6%) .044 (.010 - .188)*** .045 (.010 - .200)* .088 (.019 -.402)*** 
Sex      
Male 502 97 (19.3%) - - - 
Female 536 87 (16.2%) .809 (.588 - 1.113) .699 (.488 - 1.003) .608 (.417 -.888)* 
Living location      
Suburb, Town, Rural 786 111 (14.1%) - - - 
City 255 73 (28.6%) 2.439 (1.740 - 3.419)*** 1.776 (1.211 - 2.604)** 1.831 (1.228 -2.730)** 
Lost Income      
No 596 84 (14.1%) - - - 
Yes 445 100 (22.5%) 1.767 (1.282 - 2.434)** 1.241 (.870 - 1.772) 1.054 (.725 -1.530) 
Children at home      
No 628 81 (12.9%) - - - 
Yes 413 103 (24.9%) 2.244 (1.625 - 3.098)*** 1.460 (1.011 - 2.110)* 1.490 (1.015 - 2.187)* 
Lone adult      
No  849 155 (18.3%) - - - 
Yes 192 29 (15.1%) .797 (.517 - 1.227) 1.180 (.723 - 1.925) 1.065 (.639 -1.773) 
Pre-existing health 
condition 
     
No 867 149 (17.2%) - - - 
Yes 174 35 (20.1%) 1.213 (.805 - 1.829) 1.665 (1.034 -  2.679)* 1.601 (.982 -2.610) 
Personal Risk 1month      
Low 374 30 (8.0%) - - - 
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Moderate 448 75 (16.7%) 2.306 (1.473 - 3.609)*** 2.645 (1.654 - 4.229)*** 2.322 (1.432 -3.768)** 
High 219 79 (36.1%) 6.470 (4.068 - 10.291)*** 5.664 (3.477 - 9.226)*** 4.747 (2.871 -7.851)*** 
Anxiety/Depression      
No 753 73 (9.7%) -  - 
Yes 288 111 (38.5%) 5.842 (4.164 - 8.195)***  4.032 (2.740 -5.933)*** 
